Ansell Limited (ANSLF) Fair Value & Analysis
Healthcare · US · Market cap $3.4B
Ansell Limited
ANSLF · US
Fair value as of: Jul 14, 2026
From 24 valuation models · updated 9 days ago
Share price +10.5% over the past month.
Price vs Fair Value (12 months)
12‑month range $0.0100 – $28.45 · fair‑value band $7.37 – $12.99 · the $21.64 price screens above the $10.40 fair value. As of Jul 14, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Ansell Limited (ANSLF) currently trades at $21.64, while our model-based Fair Value estimate is $10.40, implying the stock looks roughly 52.0% overvalued today. We read business quality at 52/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Ansell Limited generated revenue of $2.0B at a net margin of 6.7%. Revenue grew 0.7% year over year. It earns a return on equity of 7.0%. Net debt stands at $567M. Fundamentals as of Jul 14, 2026
Our scenario range runs from $7.37 (bear case) to $12.99 (bull case); at $21.64, the current price sits above that range. The share trades about 13% below its 52-week high and 10% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -38% fair-value upside, at -52%, ANSLF screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 14, 2026. TTM = trailing twelve months.
About the company
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first responders, manufacturers, auto repair shops, chemical plants, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for various industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, utilities, logistics, and first responders. It sells provides its products …
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Ansell Limited reported revenue of $2.0B in FY2025 versus $2.0B in FY2021, a compound −0.3%/yr. Reported net income was $102M in FY2025, compounding −19.9%/yr from FY2021.
Is ANSLF fairly valued? → Check now
Recent news
- Personal Protective Equipment (PPE) Global Market Forecast to 2031 Featuring 3M, Protective Industrial Products, Ansell, DuPont de Nemours,
- Personal Protective Equipment Market to Reach USD 34.22 Billion by 2031 | 3M, DuPont, Ansell, MSA, and 37 Key Players Profiled | Arizton
- Ansell Announces Greenovation(TM) Awards for Sustainability Leadership and Waste Reduction
- Ansell Unveils New Disposable Glove With Extended Acetone Resistance
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection, not financial advice.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Jul 14, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | C$20.93 | C$9.25 | -56% |
| EssilorLuxottica Société anonyme ESLOF | $205.86 | $114.90 | -44% |
| Medline Inc MDLN | $41.11 | $30.15 | -27% |
| HOYA Corporation HOCPY | $162.33 | $101.00 | -38% |
| Becton, Dickinson and Company BDX | $149.56 | $117.04 | -22% |
| Alcon Inc ALC | $66.11 | $36.99 | -44% |
| ResMed Inc RMD | $196.04 | $185.14 | -6% |
| West Pharmaceutical Services, Inc WST | $336.39 | $143.45 | -57% |
| Terumo Corporation TRUMF | $12.89 | $12.65 | -2% |
| Straumann Holding SAUHY | $12.16 | $5.50 | -55% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Ansell Limited (ANSLF) undervalued?
What is the fair value of ANSLF?
What is the quality score of ANSLF?
What is the revenue of Ansell Limited (ANSLF)?
What is the net profit margin of ANSLF?
Does Ansell Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Unlock the full Ansell Limited analysis, and try Pro free
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.